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Introduction
Meningioma is a common benign idiopathic extra-axial 
tumor arising in the outer layer of the leptomeninges from 
arachnoid cap cells.1 Primary or metastasis brain tumors 
typically lead to the development of focal neurological 
deficits, such as hemiparesis, sensory deficiency, and 
aphasia. However, the external compression of the frontal 
lobes by meningioma does not cause any symptoms other 
than gradual changes in personality and comprehension 
until they are substantially enlarged, leading to its 
recognized diagnosis as a “silent tumor”.2
Meningiomas, as the most commonly seen intracranial 
tumors, account for approximately 13%–26% of 
intracranial tumors. Most of them are slow-growing, and 
many are parenthetically defined.3 While the etiology 
of meningioma is unclear, researchers believe that these 
tumors occur irregularly and may be associated with 
neurofibromatosis 2 (NF2), meningioangiomatosis (MA) 
and Gorlin syndrome as a family syndrome.1,4
The clinical symptoms are typically based on the 
anatomical location.5 We present a woman with depression 
and changes in personality, which displayed space-
occupying lesions on further examination, indicating a 
giant frontal meningioma which we successfully removed. 
Case Presentation
A 24-year-old woman without a prior medical and 
psychological history was referred for inappropriate 
activity to a psychiatric clinic. She mainly had signs of 
depression, changes in personality, and was easily irritable, 
frustrated, and mentally stressed. With low memory and 
blurred vision, she had been forgetful as well. She had 
no history of head trauma, neurological focal deficit, or 
mental illness. She never consumed or smoked alcohol 
and did not use any illicit drugs.
She was found to be time, place, and person-oriented 
on examination but had low attention and focus with 
poor judgments. Her score on the Mini-Mental State 
Examination score was 25/30. With a pulse rate of 70 
beats/min, her blood pressure was 120/70 mm Hg. 
Fundoscopy did not show pink papillae, or any border 
or hemorrhage. Neurological investigations were all 
unremarkable, including cranial nerve and other systemic 
examinations. The results of her blood test were normal. A 
brain magnetic resonance imaging (MRI) was requested, 
and the results showed a well-defined significantly 
enhancing lesion in the left frontal region measuring 65 × 
70 × 70 mm, with a fairly even edge, compression on the 
adjacent brain parenchyma with an associated significant 
A Giant Frontal Meningioma with Psychiatric 
Symptoms in a Young Woman: A Case Report
Thi Phuong Hoai Dinh1,2*#, Dang Thi Mai1#, Thi Mai Dieu Tran1#, Hai Duong Pham1#, Vinh Lac Nguyen1#, Thanh 
Minh Nguyen1#
1Hue University of Medicine and Pharmacy, Hue University, Hue, Vietnam
2Online Research Club (http://www.onlineresearchclub.org/)
Abstract
Background:Frontal meningioma is often asymptomatic but patients might experience psychiatric 
symptoms. Since symptoms are atypical in giant meningioma, to the best of our knowledge, we 
present a rare clinical scenario.
Case Presentation: A 24-year old female patient with no medical history presented with two months 
of depressive symptoms, personality changes such as easy irritability, and feelings of frustration and 
mental depression, as well as forgetfulness and blurred vision. Brain magnetic resonance imaging 
(MRI) revealed a well-defined markedly enhancing lesion in the left frontal region measuring 65 x 
70 x 70 mm with mass effects to the adjacent brain tissue and associated surrounding edema which 
was pressed to the frontal horn of the lateral ventricle. The patient underwent frontal unilateral 
craniotomy and excision of the tumor. After surgery, the quality of life was improved.
Conclusion: Meningioma with psychiatric symptoms is quite rare. This clinical case helps clinicians 
avoid missing symptoms and use appropriate management strategies for patients with giant 
meningiomas.
Keywords: Atypical psychiatric symptoms; Giant meningioma; Unilateral frontal craniotomy.
*Correspondence to
Dinh Thi Phuong Hoai, Hue 
University of Medicine and 




#Authors equally contributed to 
the work.
Published online March 27, 
2021
Int Clin Neurosci J. 2021 Spring;8(2):99-102                                                        Case Report
International Clinical
Neuroscience Journal
© 2021 The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original 
work is properly cited.
doi:10.34172/icnj.2021.21
Citation: Dinh TPH, Mai DT, Tran TMD, Pham HD, Nguyen VL, Nguyen TM. A Giant Frontal Meningioma with Psychiatric Symptoms 
in a Young Woman: A Case Report. Clin Neurosci J. 2021;8(2):99-102. doi:10.34172/icnj.2021.21.
Open Access
Scan to access more
free content
Hoai et al
Int Clin Neurosci J. Vol 8, No 2, Spring 2021100 journals.sbmu.ac.ir/Neurosciencehttp
surrounding edema. The highly contrast-absorbing mass 
was quite homogeneous after injection, and contained 
a necrotic material that was not contrast-absorbing. 
The mass pushed on both sides of the frontal horn of 
the ventricle, moving the middle line by 23 mm. These 
characteristics are consistent with a giant left frontal 
meningioma (Figure 1). Unilateral frontal craniotomy 
and tumor excision was done for the patients.
The purpose of the patient’s operation was complete 
tumor resection with maximum function preservation 
of the regions of the brain related to insight. The patient 
was placed in a supine position during surgery with her 
head securely fixed with the Mayfield frame. Her hair was 
shaved after general anesthesia and the location of the skin 
incision site was marked (Figure 1), followed by povidone-
iodine draping. A skin incision was made. Initial bone 
drilling and osteotomy were performed. Tack-up sutures 
were laid down and opened up the dura. The tumor was 
seen attached to the dura and we accomplished complete 
tumor resection after thorough debulking of the tumor 
in a piece by piece manner. The complete hemostasis was 
secured and the bone flap replaced with plates and screws. 
The drain tube was put in place and the skin closed in 
layers. The patient was admitted to the intensive care 
unit for neurosurgical therapy. Postoperative brain MRI 
indicated complete resection of the tumor (Figure 2). 
Grade I meningioma as classified by the World 
Health Organization on pathology (Figure 3). The 
patient was referred to the neuropsychology clinic for a 
neuropsychological examination two months after the 
surgery. Since surgery, her symptoms were resolved and 
her quality of life has increased considerably. 
Discussion
Meningioma is a slow-growing disease of the meninges. 
Ninety percent of meningiomas are benign and arise 
in the brain. Middle-age women are more than twice 
as likely as to experience meningioma than men. Many 
meningiomas develop during 30-70 years of age.5 This 
tumor occurs occasionally in children and adolescents 
6 and if not detected early and treated, it appears to 
develop into giant proportions and infiltrate surrounding 
tissues in early adulthood. This tumor is typically silent 
with no specific clinical manifestations. Studies have 
shown that during the luteal stage of the menstrual cycle 
and pregnancy, meningiomas change in size, and when 
estrogen agonist therapy is completed, they eventually 
worsen.1,7 Due to her age and early tumor recurrence, the 
treatment of the condition becomes more difficult. The 
World Health Organization grade I progesterone receptor, 
which is a strong prognostic predictor, is overwhelmingly 
optimistic. Chromosome 14 and 22 mutations, as well 
as molecular markers identified in meningothelial cell 
Figure 1. (A) Preparing for the removal of left frontal meningioma 
by microsurgery before surgery. (B) (axial) – (C) (coronal). The 
mass presses both sides of the frontal horn of the lateral ventricle, 
the middle line has shifted 23 mm.
Figure 2. (A) Patient re-examination after 1 month of surgery. (B) 
Postoperative MRI-brain indicated complete resection of tumor.
Figure 3. (A) Meningioma after surgery. (B). Meningioma WHO 
grade 1.
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neoplastic changes, can be associated with elevated 
levels of estrogen receptor secretion.4,8 Meningioma has 
been associated with many family cancer predisposition 
syndromes that include gene-related syndromes with 
NF1, PTCH, CREBBP, VHL, PTEN, and CDKN2A.1,9 
Susceptibility to ionizing radiation (IR) is actually the 
primary environmental risk factor for meningioma.1,9-11
Neurological symptoms, such as headaches, seizures, 
upper and lower limb fatigue, and sensory and visual 
disturbances are typically caused by meningioma. The 
patient’s signs and symptoms are usually determined 
by the growth of the lesion and the site involved.12 The 
strong association between psychological conditions and 
the location of the lesions has been previously reported12,13 
Depression is found predominantly in frontal convexity 
meningioma. Meningiomas of the bifrontal and sphenoid 
wing mainly present with mania or depression; and 
meningiomas with suprasellar lesions and temporal 
convexity often present with psychotic disorders.12 The 
seizures and tremors may be partly related to artery 
compression by the meningiomas at the left frontoparietal 
gyrus of a developing brain and partly due to intermittent 
disruption of the superior sagittal sinus and collateral 
or both, resulting in cerebral hypoxia and then seizures. 
The gold standard for preoperative examination is 
digital subtraction angiography and magnetic resonance 
angiography.14,15
Meningiomas have the “dural tail” on MRI. Ki-67 
labeling index is used to measure the growing cells 
inside a tumor and MIB-1 monoclonal antibody is used 
to stain the Ki-67 antigen in histopathological estimates 
of the possible tumor growth.4,16 Experiments have 
shown elevated Ki-67 labeling indices in childhood 
and adolescent meningiomas but elevation does not 
predict relapse or prognosis.4,17 In comparison, positive 
GFAP cells have been associated with intrusive blood 
vessel-attached meningiomas.18 S-100 protein may help 
differentiate between meningiomas and schwannomas, 
while 90% of fibrous meningiomas are typically expressed 
as S-100 protein.3,19 Early diagnosis is really critical for our 
patient, since meningioma is typically benign and curable. 
As personality changes intensify, a delay in diagnosis can 
result in chronic disappointment for the family of the 
patient. Initially, our patient was diagnosed with suicidal 
symptoms, but then experienced some atypical symptoms 
that could not be clarified by any psychiatric diagnosis. 
This is an instance of a changeable clinical situation 
that needs early diagnosis and have a multi-discipline 
management approach subsequently.
A total tumor resection (Simpson I) is the medication 
of choice when a meningioma is in an available position 
to avoid recurrence and improve prognosis. Owing to 
their larger size, irregular location, and tight adhesion of 
the tumor to nerves and essential vessels, are challenging 
for surgical resections. Studies have shown that during 
operation, the cerebral veins that act as the normal 
drainage pathway, as well as those that can provide 
important collateral drainage, should be well-maintained 
and when the venous outflow is disrupted, venous 
infarction follows, leading to brain swelling, hemorrhage, 
and neuronal death. In general, slow and persistent venous 
occlusion is well-accepted, whereas acute occlusion can 
be disastrous. The maintenance of collateral drainage 
was further emphasized by researchers, since the sudden 
loss of superficial venous drainage due to destruction or 
thrombosis of the draining veins following surgery also 
contributes to neurological deficits.20,21
Conclusion
Seeing giant meningiomas in a young adults is really 
rare. A matter of debate between neurosurgeons is still 
the cause of meningioma. Particularly for frontal lobe 
meningioma, clinical symptoms are atypical. If there is 
an irregular suspicion of psychological problems with the 
traditional “dural sign”, MRI could be used. A total tumor 
resection to prevent recurrence and improve prognosis is 
the therapeutic option.
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